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Identity 
Other names: CBL2 




CBL (11q23) - Courtesy Mariano Rocchi, Resources for 
Molecular Cytogenetics.  
DNA/RNA 
Transcription 
10.5 kb; 2718 bp open reading frame. 
Protein 
Description 
906 amino acids; 115 kDa; the evolutionarily 
conserved amino-terminal region of CBL is composed 
of three interacting domains: a four-helix bundle (4H), 
an EF-hand calcium binding domain, and a divergent 
SH2 domain; the three domains together form an 
integrated phosphoprotein-recognition module; this 
aminoterminal region is followed by a central Ring 
finger with a Cys3HisCys4 motif and a carboxy- 
terminal region with multiple proline-rich sequences, a 
putative leucine zipper and several potential tyrosine 
phosphorylation sites. 
Expression 
Ubiquitous but predominant in hematopoietic cells. 
Localisation 
Cytoplasmic; cellular activation induces translocation 
of CBL to the plasma membrane or cytoskeleton. 
Function 
CBL has been shown to have a negative regulatory 
activity in protein tyrosine kinase-mediated signali g 
pathways; CBL overexpresion inhibits cell growth 
resulting from activation of the EGF and PDGF 
receptors (EGFR, PDGFRa, PDFFRb) and enhances 
ubiquitination and degradation of these receptors; CBL 
also negatively regulates the tyrosine phosphorylation 
of ZAP70 substrates in T cells. 
Mutations 
Germinal 
The fragile site FRA11B has been localized to a stretch 
of CCG trinucleotides found in the 5' part of the CBL 
gene and has been involved in the pathogenesis of a 
proportion of inherited Jacobsen syndroms (OMIM 
147791) which have a del(11)(q23qter) telomeric of an 
expansion of the stretch of CCG tripletsSOMATIC in 
9% of the genetically unstable sporadic gastrointestinal 
tumors, an extension of an ATG trinucleotide repeat 
with no translation shift was detected in the coding 
region of CBL; this alteration was not present in 
cancers without the mutator phenotype 
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Gastrointestinal tumors (see above) 
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